A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)

Clinical trial NCT04771897 · TERMINATED

Trial details

NCT number

NCT04771897

Sponsor

Bexion Pharmaceuticals, Inc.

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2021-05-24

Primary completion

2024-10-04

Enrollment

10

View on ClinicalTrials.gov